Various systemic therapies for psoriasis either reduced, slightly increased or had no effect on risk for major adverse ...

Ultrasound-detected bursitis and higher baseline BMI are associated with the development of musculoskeletal symptoms in ...

A new study published in the journal of Photodermatology, Photoimmunology and Photomedicine showed that people with psoriasis ...

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 10, Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) announced enrolling the ...

Researchers have identified in a new study that increased serum 25-hydroxyvitamin D (25(OH)D) is linked with lower risks of ...

This excerpt from ‘Glowing Skin and Gorgeous Hair’ explains how our skin is a window into our emotional and mental health ...

Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve (roflumilast) for atopic ...

Autoimmune disease affects 50 million Americans. Learn early warning signs like fatigue, brain fog, and joint pain doctors ...

Discover why nails separate from the nail bed, what causes onycholysis, and how to treat this common but concerning nail ...

ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in adult and pediatric patients 6 years of age and older. ZORYVE cream, 0.15%, is indicated ...

Two recent studies suggest there is no significant benefit of early biologics over standard step-up care with methotrexate2,3, but these did not ...